A strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: Results from the National Health and Examination Survey 1999-2002

Diabetes Care

Volumn 29, Issue 7, 2006, Pages 1638-1644

  Lee, Duk Hee ^a   Lee, In Kyu ^a   Song, Kyungeun ^a   Steffes, Michael ^b   Toscano, William ^a,c   Baker, Beth A ^a,c,d   Jacobs Jr , David R ^c,e  

^a Kyungpook National University School of Medicine   (South Korea)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d REGIONS HOSPITAL   (United States)

^e UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,4,6,7,8 HEPTACHLORODIBENZO 4 DIOXIN; 1,2,3,4,6,7,8,9, OCTACHLORODIBENZO 4 DIOXIN; 2,2',4,4',5,5' HEXACHLOROBIPHENYL; 4,4' DICHLORODIPHENYLTRICHLOROETHANE; DIOXIN; ETHANE; NONACHLOR; OXYCHLORDANE; PESTICIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DOSE RESPONSE; ETHNOLOGY; HEALTH SURVEY; HISPANIC; HUMAN; LOWEST INCOME GROUP; OBESITY; ORGANIC POLLUTION; POLLUTANT; PREVALENCE; RACE DIFFERENCE; RISK FACTOR; WAIST CIRCUMFERENCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; BODY MASS INDEX; CHLORDAN; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DICHLORODIPHENYL DICHLOROETHYLENE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYDROCARBONS, CHLORINATED; MALE; MEXICAN AMERICANS; MIDDLE AGED; POLYCHLORINATED BIPHENYLS; TETRACHLORODIBENZODIOXIN; UNITED STATES;

EID: 33746422641     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-0543     Document Type: Article

References (40)

1. Fisher BE: Most unwanted. Environ Health Perspect 107:A18-A23, 1999
2. Abelsohn A, Gibson BL, Sanborn MD, Weir E: Identifying and managing adverse environmental health effects. 5. Persistent organic pollutants. CMAJ 166:1549-1554, 2002
3. Remillard RB, Bunce NJ: Linking dioxins to diabetes: epidemiology and biologic plausibility. Environ Health Perspect 110:853-858, 2002
4. Henriksen GL, Ketchum NS, Michalek JE, Swaby JA: Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand. Epidemiology 8:252-258, 1997
5. Bertazzi PA, Bernucci I, Brambilla G, Consonni D, Pesatori AC: The Seveso studies on early and long-term effects of dioxin exposure: a review. Environ Health Perspect 106 (Suppl. 2):625-633, 1998
6. Vena J, Boffetta P, Becher H, Benn T, Bueno-de-Mesquita HB, Coggon D, Colin D, Flesch-Janys D, Green L, Kauppinen T, Littorin M, Lynge E, Mathews JD, Neuberger M, Pearce N, Pesatori AC, Saracci R, Steenland K, Kogevinas M: Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers. Environ Health Perspect 106 (Suppl. 2):645-653, 1998
7. Steenland K, Piacitelli L, Deddens J, Fingerhut M, Chang LI: Cancer, heart disease, and diabetes in workers exposed to 2,3,7,8-tetrachlorodibenzo-p- dioxin. J Natl Cancer Inst 91:779 -786, 1999
8. Longnecker MP, Michalek JE: Serum dioxin level in relation to diabetes mellitus among Air Force veterans with background levels of exposure. Epidemiology 11:44-48, 2000
9. Sweeney MH, Calvert GM, Egeland GA, Fingerhut MA, Halperin WE, Piacitelli LA: Review and update of the results of the NIOSH medical study of workers exposed to chemicals contaminated with 2,3,7,8-tetrachlorodibenzodioxin. Teratog Carcinog Mutagen 17:241-247, 1997-1998
10. Zober A, Ott MG, Messerer P: Morbidity follow up study of BASF employees exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) after a 1953 chemical reactor incident. Occup Environ Med 51:479-486, 1994
11. Testimony of Ronald Ziegler before the Joint Session of the Committees on Veterans Affairs, United States House of Representatives and United States Senate on Veterans Legislative Agenda for 2001. Available from http://veterans.house.gov/hearings/schedule107/mar01/3-8-01/rziegler.htm. Accessed 28 February 2006.
12. Hankinson O: The aryl hydrocarbon receptor complex. Annu Rev Pharmacol Toxicol 35:307-340, 1995
13. Enan E, Lasley B, Stewart D, Overstreet J, Vandevoort CA: 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) modulates function of human luteinizing granulosa cells via cAMP signaling and early reduction of glucose transporting activity. Reprod Toxicol 10:191-198, 1996
14. Olsen H, Enan E, Matsumura F: Regulation of glucose transport in the NIH 3T3 L1 preadipocyte cell line by TCDD. Environ Health Perspect 102:454-458, 1994
15. Enan E, Matsumura F: 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced changes in glucose transporting activity in guinea pigs, mice, and rats in vivo and in vitro. J Biochem Toxicol 9:97-106, 1994
16. Liu PC, Matsumura F: Differential effects of 2,3,7,8-tetrachlorodibenzo- p-dioxin on the "adipose-type" and "brain-type" glucose transporters in mice. Mol Pharmacol 47:65-73, 1995
17. Dohr O, Vogel C, Abel J: Modulation of growth factor expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Exp Clin Immunogenet 11:142-148, 1994
18. Vogel C, Abel J: Effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on growth factor expression in the human breast cancer cell line MCF-7. Arch Toxicol 69:259-265, 1995
19. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM: Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 95:2409-2415, 1995
20. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
21. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389:610-614, 1997
22. Gunton JE, Kulkarni RN, Yim S, Okada T, Hawthorne WJ, Tseng YH, Roberson RS, Ricordi C, O'Connell PJ, Gonzalez FJ, Kahn CR: Loss of ARNT/HIF1beta mediates altered gene expression and pancreatic-islet dysfunction in human type 2 diabetes. Cell 122:337-349, 2005
23. Third national report on human expoure to environmental chemicals [article online], 2005. Available from http:// www.cdc.gov/exposurereport/3rd/ pdf/thirdreport.pdf. Accessed 28 February 2006
24. NHANES 1999-2000 public data release file documentation [article online], 2005. Available from http://www.cdc.gov/nchs/about/major/nhanes/nhanes99-00. htm. Accessed 28 February 2006
25. NHANES 2000-2001 public data release file documentation [article online], 2005. Available from http://www.cdc.gov/nchs/about/major/nhanes/nhanes01-02. htm. Accessed 28 February 2006
26. Turner W, DiPietro E, Lapeza C, Green V, Gill J, Patterson DG Jr: A fast universal automated cleanup system for the isotope-dilution HRMS analysis of PCDDs, PCDFs, coplanar PCBs, PCB congeners, and persistent pesticides from the same serum sample. Organohalogen Comp 31:26-31, 1997
27. Korn EL, Graubard BI: Epidemiologic studies utilizing surveys: accounting for the sampling design. Am J Public Health 81:1166-1173, 1991
28. Graubard BI, Korn EL: Analyzing health surveys for cancer-related objectives. J Natl Cancer Inst 91:1005-1016, 1999
29. DeVito MJ, Birnbaum LS, Farland WH, Gasiewicz TA: Comparisons of estimated human body burdens of dioxin-like chemicals and TCDD body burdens in experimentally exposed animals. Environ Health Perspect 103:820-831, 1995
30. Olson JR: Pharmacokinetics of dioxins and related chemicals. In Dioxins and Health. Schecter A, Ed. New York, Plenum Press, 1994, p. 163-197
31. Michalek JE, Ketchum NS, Tripathi RC: Diabetes mellitus and 2,3,7,8-tetrachlorodibenzo-p-dioxin elimination in veterans of Operation Ranch Hand. J Toxicol Environ Health 66:211-221, 2003
32. Needham LL, Barr DB, Caudill SP, Pirkle JL, Turner WE, Osterloh J, Jones RL, Sampson J: Concentrations of environmental chemicals associated with neurodevelopmental effects in U.S. population. Neurotoxicology 26:531-545, 2005
33. Masuda Y: Fate of PCDF/PCB congeners and change of clinical symptoms in patients with Yusho PCB poisoning for 30 years. Chemosphere 43:925-930, 2001
34. Masuda Y, Schecter A, Papke O: Concentrations of PCBs, PCDFs and PCDDs in the blood of Yusho patients and their toxic equivalent contribution. Chemosphere 37:1773-1780, 1998
35. van den Berg M, Peterson RE, Schrenk D: Human risk assessment and TEFs. Food Addit Contam 17:347-358, 2000
36. Tritscher AM, Goldstein JA, Portier CJ, McCoy Z, Clark GC, Lucier GW: Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo- p′-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver. Cancer Res 52:3436-3442, 1992
37. Hennig B, Meerarani P, Slim R, Toborek M, Daugherty A, Silverstone AE, Robertson LW: Proinflammatory properties of coplanar PCBs: in vitro and in vivo evidence. Toxicol Appl Pharmacol 181:174-183, 2002
38. Neubert D: Reflections on the assessment of the toxicity of "dioxins" for humans, using data from experimental and epidemiological studies. Teratog Carcinog Mutagen 17:157-215, 1997-1998
39. Kern PA, Fishman RB, Song W, Brown AD, Fonseca V: The effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on oxidative enzymes in adipocytes and liver. Toxicology 171:117-125, 2002
40. Ebner K, Matsumura F, Enan E, Olsen H: 2,3,7,8-Tetrachlorodibenzo-p- dioxin (TCDD) alters pancreatic membrane tyrosine phosphorylation following acute treatment. J Biochem Toxicol 8:71-81, 1993